Olema Oncology to Present New Palazestrant Clinical Data in

Presentations detailing initial Phase 1b clinical data for palazestrant in combination with ribociclib, a Poster Spotlight Session on Phase 2 clinical data for palazestrant in combination with...

Related Keywords

Texas , United States , Cambridge , Cambridgeshire , United Kingdom , San Francisco , California , Massachusetts , Nedlands , Western Australia , Australia , San Antonio , Hollywood , Marlene Chan , Geoffrey Mogilner , Company Investor Webcast , Novel Nuclear Receptor Targeting Therapies , Breast Cancer Research , Henryb Gonzalez Convention Center , Nasdaq , Linkedin , Twitter , Olema Pharmaceuticals Inc , Curtin University , Poster Spotlight Session , San Antonio Breast Cancer Symposium , Convention Center , Breast Clinical Trials Unit , Hollywood Private Hospital , Night Ballroom , Investor Webcast , Vice President , Investor Relations , Markets ,